연구동향 분석

Serum lactate dehydrogenase is a possible predictor of platinum resistance in ovarian cancer

Asami Ikeda Ken Yamaguchi Hajime Yamakage Kaoru Abiko Noriko Satoh-Asahara Kenji Takakura Ikuo Konishi 2020년

논문상세정보
인용/피인용
' Serum lactate dehydrogenase is a possible predictor of platinum resistance in ovarian cancer' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Lactate dehydrogenase
  • Ovarian cancer
  • chemotherapy
  • platinum
  • serum
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
527 0

0.0%

' Serum lactate dehydrogenase is a possible predictor of platinum resistance in ovarian cancer' 의 참고문헌

  • Understanding the Warburg effect : the metabolic requirements of cell proliferation
  • The prognostic value of the serum neuron specific enolase and lactate dehydrogenase in small cell lung cancer patients receiving first-line platinum-based chemotherapy
    Liu X [2017]
  • The positive predictive value of low-density lipoprotein for recurrence-free survival in ovarian cancer
    Zhu F [2018]
  • The influence of metabolism on drug response in cancer
    Zaal EA [2018]
  • The clinical value of lactate dehydrogenase in serum : a quantitative review
    Huijgen HJ [1997]
  • Significance of serum and peritoneal fluid lactate dehydrogenase levels in ovarian cancer
    Boran N [2000]
  • Serum lowdensity lipoprotein levels correlate with survival in advanced stage epithelial ovarian cancers
    Li AJ [2010]
  • Serum lactate dehydrogenase and survival following cancer diagnosis
  • Serum C-reactive protein as independent prognostic variable in patients with ovarian cancer
    Hefler LA [2008]
  • Prognostic significance of platelet-to-lymphocyte ratio in patients with ovarian cancer : a meta-analysis
    Tian C [2018]
  • Prognostic role of neutrophil to lymphocyte ratio in ovarian cancer : a meta-analysis
    Chen G [2018]
  • Pretreatment neutrophil-to-lymphocyte ratio and its dynamic change during neoadjuvant chemotherapy as poor prognostic factors in advanced ovarian cancer
    김윤지 [2018]
  • Preoperative neutrophil-to-lymphocyte ratio predicts response to first-line platinum-based chemotherapy and prognosis in serous ovarian cancer
    Wang Y [2015]
  • Optimal primary surgical treatment for advanced epithelial ovarian cancer
    Elattar A [2011]
  • Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are predictive of chemotherapeutic response and prognosis in epithelial ovarian cancer patients treated with platinum-based chemotherapy
    Miao Y [2016]
  • Lactic dehydrogenase and cancer: an overview
    Gallo M [2015]
  • Lactate dehydrogenase is correlated with clinical stage and grade and is downregulated by si‑SATB1 in ovarian cancer
    Xiang J [2018]
  • Inflammation and cancer
    Coussens LM [2002]
  • Glucose as a prognostic factor in ovarian carcinoma
    Lamkin DM [2009]
  • Evaluation of the sensitivity and specificity of serum level of prostasin, CA125, LDH, AFP, and hCG+β in epithelial ovarian cancer patients
    Bastani A [2017]
  • Evaluation of factors associated with platinum-sensitivity status and survival in limited-stage small cell lung cancer patients treated with chemoradiotherapy
    Wen Q [2017]
  • Cancer statistics, 2019
    Siegel RL [2019]
  • Baseline serum lactate dehydrogenase level predicts survival benefit in patients with metastatic colorectal cancer receiving bevacizumab as first-line chemotherapy : a systematic review and metaanalysis of 7 studies and 1, 219 patients
    Feng W [2019]
  • An explorative analysis of the prognostic value of lactate dehydrogenase for survival and the chemotherapeutic response in patients with advanced triple-negative breast cancer
    Jia Z [2018]
  • "Platinum resistant"ovarian cancer : what is it, who to treat and how to measure benefit?
    Davis A [2014]